Page last updated: 2024-10-24

chlorambucil and Stomatitis, Aphthous

chlorambucil has been researched along with Stomatitis, Aphthous in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Stomatitis, Aphthous: A recurrent disease of the oral mucosa of unknown etiology. It is characterized by small white ulcerative lesions, single or multiple, round or oval. Two to eight crops of lesions occur per year, lasting for 7 to 14 days and then heal without scarring. (From Jablonski's Dictionary of Dentistry, 1992, p742)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pivetti Pezzi, P1
Gasparri, V1
De Liso, P1
Catarinelli, G1

Other Studies

1 other study available for chlorambucil and Stomatitis, Aphthous

ArticleYear
Prognosis in Behcet's disease.
    Annals of ophthalmology, 1985, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Behcet Syndrome; Central Nervous System Diseases; Chlorambucil; Eye Diseases; Fem

1985